Cutaneous reactions to chemotherapy

Jessica A. Savas, Reshma Mahtani

Research output: Chapter in Book/Report/Conference proceedingChapter


Patients undergoing cancer chemotherapy are often challenging to physicians from a management standpoint due to an unfortunate combination of general poor health, immunosuppression, and multi-drug regimens. Several chemotherapeutic agents are associated with well-described mucocutaneous toxicities. This chapter will address the commonly encountered adverse events associated with traditional chemotherapy medications such as chemotherapy- induced alopecia, mucositis, extravasation reactions, dyschromia, and acral erythema, among others. This will be followed by a discussion of the cutaneous toxicities associated with newer agents, namely, targeted therapies such as monoclonal antibodies and tyrosine kinase inhibitors. Finally, a brief discussion of radiation recall and enhancement is also included. By addressing important considerations in the recognition, diagnosis, and management of the cutaneous effects of cancer treatment, additional morbidity and potential mortality can be avoided in this already at-risk patient population.

Original languageEnglish (US)
Title of host publicationSkin Diseases in the Immunocompromised
PublisherSpringer-Verlag London Ltd
Number of pages12
ISBN (Print)9781447164791, 1447164784, 9781447164784
StatePublished - May 1 2014


  • Alopecia
  • Blocking antibodies
  • Cancer
  • Chemotherapy
  • Immunosuppression
  • Kinase inhibitors
  • Mucocutaneous
  • Mucositis

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Cutaneous reactions to chemotherapy'. Together they form a unique fingerprint.

Cite this